Barbara Biedrzycki

Research Associate

20012015
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Oncology Nursing Medicine & Life Sciences
Nurse's Role Medicine & Life Sciences
Cancer Vaccines Medicine & Life Sciences
Granulocyte-Macrophage Colony-Stimulating Factor Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Patient Education Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2015

PD-1 blockade in tumors with mismatch-repair deficiency

Le, D. T. , Uram, J. N. , Wang, H. , Bartlett, B. R. , Kemberling, H. , Eyring, A. D. , Skora, A. D. , Luber, B. S. , Azad, N. S. , Laheru, D. , Biedrzycki, B. , Donehower, R. C. , Zaheer, A. , Fisher, G. A. , Crocenzi, T. S. , Lee, J. J. , Duffy, S. M. , Goldberg, R. M. , De La Chapelle, A. , Koshiji, M. & 15 others Bhaijee, F., Huebner, T., Hruban, R. H., Wood, L. D., Cuka, N., Pardoll, D. M., Papadopoulos, N., Kinzler, K. W., Zhou, S., Cornish, T. C., Taube, J. M., Anders, R. A., Eshleman, J. R., Vogelstein, B. & Diaz, L. A., Jun 25 2015, In : New England Journal of Medicine. 372, 26, p. 2509-2520 12 p.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Colorectal Neoplasms
Neoplasms
Disease-Free Survival
Survival Rate

Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine

Laheru, D., Biedrzycki, B. & Jaffee, E. M., 2013, Methods in Molecular Biology. Humana Press Inc., Vol. 980, p. 175-203 29 p. (Methods in Molecular Biology; vol. 980)

Research output: Chapter in Book/Report/Conference proceedingChapter

Cancer Vaccines
Pancreatic Neoplasms
Cytokines
Survival

A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma: A phase II trial of safety, efficacy, and immune activation

Eric, L., Yeo, C. J., Lillemoe, K. D., Biedrzycki, B., Kobrin, B., Herman, J., Sugar, E., Piantadosi, S., Cameron, J. L., Solt, S., Onners, B., Tartakovsky, I., Choi, M., Sharma, R., Illei, P. B., Ralph H., H., Abrams, R. A., Le, D., Elizabeth, J. & Laheru, D., Feb 2011, In : Annals of Surgery. 253, 2, p. 328-335 8 p.

Research output: Contribution to journalArticle

Cancer Vaccines
Granulocyte-Macrophage Colony-Stimulating Factor
Immunotherapy
Adenocarcinoma
Safety

Factors and outcomes of decision making for cancer clinical trial participation

Biedrzycki, B. A., Sep 2011, In : Oncology Nursing Forum. 38, 5, p. 542-552 11 p.

Research output: Contribution to journalArticle

Decision Making
Clinical Trials
Research
Neoplasms
Hope
Clinical Trials
Research
Neoplasms
Gastrointestinal Neoplasms
National Cancer Institute (U.S.)